Todd R. Daviau, Ph.D., MBA

President and CEO

Todd Daviau, an accomplished scientific leader, brings almost 30 years of pharmaceutical experience and knowledge to CoreRx, as well as being one of principal founders.

Prior to founding CoreRx, he served as Director of the Analytical and Pre-Formulation Laboratory for MDS Pharma Services in Tampa, FL. In this role, he directed the analytical group of over 20 scientists responsible for all the analytical, stability, and pre-formulation activities in support of over 75 stability, formulation and/or manufacturing projects.

Dr. Daviau was also a strategic analytical team member with Nova Pharmaceuticals (later Guilford Pharmaceuticals), and involved in a number of NDA programs, including the development of Gliadel®.

Todd is acknowledged as a creative leader focused on advancing projects with experience in multiple therapeutic areas. He is an expert in optimizing the drug discovery process through optimal resource allocation, process improvements and using scientific acumen to resolve complex project related issues. Todd brings a breadth of pharmaceutical experience, from drug discovery through research and development, analytical (R&D and QC.) and management experience in top-tier multinational pharmaceutical organizations. He is recognized as global, strategic thinker, with demonstrated ability to deliver pre-clinical and clinical candidates, within stringent timelines.

Dr. Daviau holds a bachelor’s degree in Marine Biology and Chemistry, a PhD in Natural Product Chemistry and an MBA in Business Management.

Tim Hudson, CPA

Chief Financial Officer

Tim Hudson has held CFO and senior level finance positions with both publicly traded and privately held companies, most recently serving as CFO with VOAF and SCI. Prior to VOAF, Tim was Corporate Controller with MDS Pharma Services and Controller Assistant, Executive Director of Finance with Hospital Corporation of America (HCA).

Tim holds a Bachelor of Science Degree in Accounting and Bachelor of Business Administration Degree in Finance from the University of Kentucky. Tim is a Certified Public Accountant in Florida and Georgia.

Janice Cacace, Ph.D.

Senior Director of Formulation Development

Dr. Janice Cacace’s career has spanned over 30 years in the pharmaceutical industry in the areas of formulation, product development, consulting and academia.

She has held management level positions involved in pharmaceutical product development for 15 years, at Sancilio and Company, Azopharma and Ivax. Her experience covers a wide range of dosage forms and product types. These include tablets, capsules, spray-dried dispersions, wet and dry granulations, soft gelatin capsules, oral liquids, topicals, injectables, medical foods, and covers both generic and new chemical entities.

Dr. Cacace holds a Bachelor of Science Degree in Pharmacy from Purdue University, and a Doctor of Philosophy in Pharmaceutics from the University of Florida.

Simon Daw

Senior Director of Operations

Simon Daw brings over 25 years of pharmaceutical manufacturing experience. Simon has worked at both brand name pharmaceuticals, CMO’s, and CRO’s specializing in: product development, manufacturing support, process engineering/validation, manufacturing management and plant management.

 Prior to joining CoreRx, he held management positions with Burroughs Wellcome, Glaxo Wellcome, Cataltyica, Novapharm, Bausch & Lomb, Lannett, and DSM Pharmaceuticals.

Simon brings extensive experience to the CoreRx manufacturing team and holds a Bachelor of Science Degree in Electrical and Electronic Engineering from the University of Bath.

Eric Primelles-Perez

Director of Analytical

Eric Primelles-Perez has held management level positions in analytical development of pharmaceutical products for nearly a decade at Wyeth, Pfizer and Nephron Pharmaceuticals. His experience covers a wide range of dosage forms and product types and includes:  tablets, capsules, soft gelatin capsules, oral liquids, inhalation solutions and suspensions, ophthalmic, injectables, dietary supplements, nutritionals, and covers both generic and new chemical entities.

 Eric holds a Bachelor of Science Degree in Chemistry from University of Las Villas, Cuba. He attended the Doctoral Program in Science (Chemistry), University of Las Villas, Cuba.

Kyle Brinkman

Director of Quality Assurance

Kyle Brinkman brings over 17 years of expertise in the pharmaceutical industry to CoreRx.  Kyle began his career as a chemist in the QC Laboratory of King Pharmaceuticals (Daniels Pharmaceuticals at the time) and progressed to Stability Supervisor overseeing nearly 200 stability studies.  As a Senior Lab Supervisor he led the work of four shifts and 24 chemists towards an approved NDA.

He then decided to take a career change to validation and increased his experience to include metrology, equipment, facility, cleaning and computer validation.  Kyle served as the chair of King’s Corporate 21 CFR Part 11 Committee for all five sites. Kyle’s most notable career achievements include a Lean Six Sigma Black Belt and a patent application for preserving the potency of Levothyroxine sodium by means of modified atmosphere packaging.

Kyle then came to CoreRx in 2012 with two years of experience as a Director of Quality from a local contract manufacturer of OTC and Nutritional products.  His leadership has been instrumental in the qualification of CoreRx’s new facility and reinvigoration of the quality systems.

Bill Reid

Executive Director and Chief Operating Officer

Bill Reid began his career as a quality control chemist at R.P. Scherer and then moved on as an analytical chemist to Bausch & Lomb developing methods to characterize nasal products.  His work there played a critical role with in-vitro bioequivalence studies which resulted in some of the first ANDA approvals for nasal products. Bill moved on from there to join MDS Pharma Services where he initially served an analytical chemist with a focus on characterization testing across a number dosage forms. He later moved into project management, where he established a strong track record of consistently delivering on projects with significant challenges and tight time lines. His proven team leadership and attention to detail resulted in great customer feedback.

Bill holds a B.S. degree in Chemistry from Delaware Valley College in Doylestown, PA.

 

Mark DaFonseca

Executive Director and Chief Business Officer

Mark DaFonseca brings nearly 20 years of pharmaceutical and business development experience across the CRO/CMO sector.

Prior to CoreRx he began his career with AAI International as an analytical chemist, followed by positions of increasing responsibility in client services and business development. From there, Mark focused on sales & marketing, successfully leading business development teams with Aptuit, Catalent, and CRMG prior to joining CoreRx. This background has provided him exposure acoss the entire drug development paradigm, including experience in discovery, preclinical, CMC and clinical trial activities.

Mark holds both a MBA in Business and a B.S. in Biology from the University of North Carolina, Wilmington.

Partner with us

When you’re ready to get expertise, flexibility, and reliability with your pharmaceutical formulation project, call us or fill out this form. We’ll be happy to answer your questions, provide a tour of our facilities, and get your project started today.